Pell Bio-Med Technology Co., Ltd. (TPE:6949)
Taiwan · Delayed Price · Currency is TWD 687.00
-29.00 (-4.05%)
May 15, 2026, 1:30 PM CST
Pell Bio-Med Technology Market Cap
Pell Bio-Med Technology has a market cap or net worth of 46.86 billion as of May 15, 2026. Its market cap has increased by 548.48% in one year.
Market Cap
46.86B
Enterprise Value
44.91B
Revenue
25.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
687.00
Market Cap Chart
Since March 8, 2024, Pell Bio-Med Technology's market cap has increased from 5.56B to 46.86B, an increase of 743.31%. That is a compound annual growth rate of 165.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 43.88B | 118.72% |
| Dec 31, 2025 | 20.06B | 324.81% |
| Dec 31, 2024 | 4.72B | -15.00% |
| Mar 8, 2024 | 5.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 151.59B |
| Lin BioScience | 33.26B |
| Oneness Biotech | 24.92B |
| Lumosa Therapeutics | 21.44B |
| Sunmax Biotechnology | 20.75B |
| Medigen Vaccine Biologics | 16.11B |
| AP Biosciences | 15.19B |
| CHO Pharma | 14.94B |